SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%
Wed, 13 Feb

SUN PHARMA has announced its results for the quarter ended December 2018. Here is a detailed performance review of the same:

SUN PHARMA Quarterly Financials

No. of Mths
Qtr. Ending
3
Dec-17*
3
Sep-18*
3
Dec-18*
QoQ ChangeYoY Change
Net SalesRs m66,53269,37677,40211.6%16.3%
Other incomeRs m1,2923,5121,931-45.0%49.4%
TurnoverRs m67,82472,88879,3338.8%17.0%
ExpensesRs m51,99954,06455,8733.3%7.5%
Gross profitRs m14,5343,16821,529579.5%48.1%
DepreciationRs m3,3934,2654,71110.4%38.8%
InterestRs m9531,2951,44811.8%51.9%
Profit before taxRs m11,4791,11917,3011445.6%50.7%
TaxRs m7,4872,1892,70923.8%-63.8%
Profit after taxRs m3,992-1,07014,592265.5%
Gross profit margin%21.84.627.8
Effective tax rate%65.2195.615.7
Net profit margin%5.9-1.518.4
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Reports, Regulatory Filings, Equitymaster


Year-on-Year Performance:
  • The company's operating income during the quarter grew 16.3% on a year-on-year (YoY) basis. The expenses were up by 7.5% YoY during the same period.
  • The company's operating profit increased by 48.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 21.8% in 3QFY18.
  • Depreciation charges increased by 38.8% and finance costs increased by 51.9% YoY, respectively.
  • Other income increased by 49.4% YoY during the quarter.
  • Net profit for the quarter increased by 265.5% YoY. Net profit margins during the quarter increased from 5.9% in 3QFY18 to 18.4% in 3QFY19.
Quarter-on-Quarter Performance:
  • The company's operating income during the quarter grew 11.6% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.3% QoQ during the same period.
  • The company's operating profit increased by 579.5% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 27.8% in 3QFY19 as against 4.6% in 2QFY18.
  • Net profit for the quarter increased by 1464.1% QoQ, while net profit margins increased from -1.5% in 2QFY18 to 18.4% in 3QFY19.

To see how SUN PHARMA has performed over the last eight quarters, please visit here.

SUN PHARMA Share Price Performance

Over the last one year, SUN PHARMA share price has moved up from Rs 589.4 to Rs 453.0, registering a Loss of Rs 136.4 or around 23.1%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 13,859.9 (up 0.7%). Over the last one year it has moved down from 14,517.2 to 13,859.9, a gain of 657 points (down 4.5%).

Overall, the S&P BSE SENSEX is up 5.8% over the year.

Current Valuations

At the current price of Rs 453.0, the price to earnings (P/E) ratio of SUN PHARMA stands at 27.2 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 2.9 times.

Equitymaster requests your view! Post a comment on "SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5%". Click here!

  

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

A Simple, 7-Step Checklist for Your Trading Success

Dec 4, 2019

What we can learn from one of the greatest traders to have ever lived.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

What Is the IPO Euphoria Signaling Us About the Markets?(The 5 Minute Wrapup)

Dec 2, 2019

2019 will be remembered as the year of great money-making IPOs...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

SUN PHARMA SHARE PRICE


Dec 13, 2019 02:45 PM

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

MARKET STATS